Zacks Research Issues Positive Outlook for THC Earnings

Tenet Healthcare Corporation (NYSE:THC) – Research analysts at Zacks Research boosted their Q4 2025 earnings estimates for Tenet Healthcare in a note issued to investors on Tuesday, November 11th. Zacks Research analyst Team now forecasts that the company will post earnings of $4.02 per share for the quarter, up from their prior estimate of $4.01. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Zacks Research also issued estimates for Tenet Healthcare’s Q1 2026 earnings at $3.73 EPS, Q2 2026 earnings at $3.68 EPS, FY2026 earnings at $15.41 EPS, Q1 2027 earnings at $4.08 EPS, Q3 2027 earnings at $4.38 EPS and FY2027 earnings at $17.98 EPS.

A number of other analysts have also recently weighed in on the company. Raymond James Financial set a $245.00 price objective on Tenet Healthcare in a research report on Wednesday, October 29th. Guggenheim boosted their price target on Tenet Healthcare from $221.00 to $238.00 and gave the stock a “buy” rating in a research note on Wednesday, October 29th. The Goldman Sachs Group initiated coverage on shares of Tenet Healthcare in a research report on Tuesday, October 14th. They issued a “buy” rating and a $224.00 price objective for the company. Morgan Stanley set a $232.00 price target on shares of Tenet Healthcare and gave the company an “overweight” rating in a research note on Wednesday, October 29th. Finally, Mizuho boosted their price objective on shares of Tenet Healthcare from $194.00 to $225.00 and gave the company an “outperform” rating in a report on Friday, October 17th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $226.25.

Tenet Healthcare Price Performance

NYSE THC opened at $198.64 on Wednesday. The firm’s fifty day simple moving average is $198.63 and its two-hundred day simple moving average is $177.57. The firm has a market capitalization of $17.46 billion, a P/E ratio of 13.61, a P/E/G ratio of 0.89 and a beta of 1.53. The company has a current ratio of 1.71, a quick ratio of 1.63 and a debt-to-equity ratio of 2.27. Tenet Healthcare has a 12-month low of $109.82 and a 12-month high of $217.43.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Tuesday, October 28th. The company reported $3.70 earnings per share for the quarter, beating analysts’ consensus estimates of $3.33 by $0.37. Tenet Healthcare had a net margin of 6.49% and a return on equity of 25.11%. The business had revenue of $5.29 billion for the quarter, compared to analysts’ expectations of $5.26 billion. During the same period last year, the business earned $2.93 EPS. The company’s revenue was up 3.2% compared to the same quarter last year. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS.

Insiders Place Their Bets

In other news, insider R. Scott Ramsey sold 13,322 shares of the stock in a transaction dated Thursday, November 6th. The shares were sold at an average price of $205.11, for a total transaction of $2,732,475.42. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Christopher S. Lynch sold 3,952 shares of the company’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $176.39, for a total value of $697,093.28. Following the completion of the transaction, the director directly owned 12,358 shares of the company’s stock, valued at $2,179,827.62. The trade was a 24.23% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 134,044 shares of company stock valued at $25,977,997. Insiders own 0.81% of the company’s stock.

Hedge Funds Weigh In On Tenet Healthcare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Nuveen LLC purchased a new stake in shares of Tenet Healthcare during the first quarter worth about $218,549,000. Ameriprise Financial Inc. increased its stake in Tenet Healthcare by 348.4% during the 1st quarter. Ameriprise Financial Inc. now owns 1,962,314 shares of the company’s stock worth $263,905,000 after buying an additional 1,524,642 shares in the last quarter. Norges Bank purchased a new position in shares of Tenet Healthcare in the second quarter valued at approximately $206,981,000. Boston Partners lifted its holdings in Tenet Healthcare by 95.0% in the 2nd quarter. Boston Partners now owns 2,267,142 shares of the company’s stock valued at $398,949,000 after purchasing an additional 1,104,500 shares in the last quarter. Finally, Alliancebernstein L.P. grew its holdings in shares of Tenet Healthcare by 375.7% during the second quarter. Alliancebernstein L.P. now owns 790,254 shares of the company’s stock worth $139,085,000 after buying an additional 624,125 shares in the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.